These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31218146)

  • 21. An update on prucalopride in the treatment of chronic constipation.
    Omer A; Quigley EMM
    Therap Adv Gastroenterol; 2017 Nov; 10(11):877-887. PubMed ID: 29147138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New pharmacological treatment options for chronic constipation.
    Corsetti M; Tack J
    Expert Opin Pharmacother; 2014 May; 15(7):927-41. PubMed ID: 24661106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
    Quigley EM; Vandeplassche L; Kerstens R; Ausma J
    Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study.
    Miner PB; Camilleri M; Burton D; Achenbach H; Wan H; Dragone J; Mellgard B
    Neurogastroenterol Motil; 2016 Sep; 28(9):1341-8. PubMed ID: 27270968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation.
    Wong BS; Manabe N; Camilleri M
    Clin Exp Gastroenterol; 2010; 3():49-56. PubMed ID: 21694846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prucalopride succinate for the treatment of constipation: an update.
    Bassotti G; Gambaccini D; Bellini M
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
    Cinca R; Chera D; Gruss HJ; Halphen M
    Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.
    Shah ED; Kim HM; Schoenfeld P
    Am J Gastroenterol; 2018 Mar; 113(3):329-338. PubMed ID: 29380823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
    Thomas RH; Luthin DR
    Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.
    Shin A; Camilleri M; Kolar G; Erwin P; West CP; Murad MH
    Aliment Pharmacol Ther; 2014 Feb; 39(3):239-53. PubMed ID: 24308797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and future therapies for chronic constipation.
    Tack J
    Best Pract Res Clin Gastroenterol; 2011 Feb; 25(1):151-8. PubMed ID: 21382586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.
    Tack J; Corsetti M
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1327-35. PubMed ID: 22985444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prucalopride.
    Frampton JE
    Drugs; 2009; 69(17):2463-76. PubMed ID: 19911858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of prucalopride in adults and children with chronic constipation.
    Diederen K; Mugie SM; Benninga MA
    Expert Opin Pharmacother; 2015 Feb; 16(3):407-16. PubMed ID: 25539475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.
    Camilleri M; Piessevaux H; Yiannakou Y; Tack J; Kerstens R; Quigley EMM; Ke M; Da Silva S; Levine A
    Dig Dis Sci; 2016 Aug; 61(8):2357-2372. PubMed ID: 27056037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Idiopathic Constipation in Adults: A Review on Current Guidelines and Emerging Treatment Options.
    Bassotti G; Usai Satta P; Bellini M
    Clin Exp Gastroenterol; 2021; 14():413-428. PubMed ID: 34712055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Prucalopride in Treating Functional Constipation and Gastroparesis: A Systemic Review.
    Ali H; Pamarthy R; Sarfraz S
    Cureus; 2021 Apr; 13(4):e14306. PubMed ID: 33968518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prucalopride. In chronic constipation: poorly documented risks.
    Prescrire Int; 2011 May; 20(116):117-20. PubMed ID: 21648173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current developments in pharmacological therapeutics for chronic constipation.
    Jiang C; Xu Q; Wen X; Sun H
    Acta Pharm Sin B; 2015 Jul; 5(4):300-9. PubMed ID: 26579459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Outcomes Before and After Prucalopride Treatment: An Observational Study in Patients With Chronic Idiopathic Constipation in the United States.
    Lembo A; Cash BD; Lu M; Terasawa E; Terreri B; Du S; Ayyagari R; Feuerstadt P; Moshiree B; Westermeyer B; Pi S; Boules M
    Clin Transl Gastroenterol; 2024 May; 15(5):e00687. PubMed ID: 38357940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.